{"tumor_context":{"somatic_mutations":[],"copy_number_alterations":[],"fusions":[],"tmb":5.2,"msi_status":null,"hrd_score":42.0,"tmb_metrics":null,"msi_metrics":null,"hrd_metrics":null,"qc":null,"ihc":null,"signatures":null,"level":"L0","priors_used":true,"completeness_score":0.5,"tumor_context_source":"Quick Intake","specimen_type":null,"report_date":null,"panel_name":null,"panel_version":null},"provenance":{"no_report_mode":true,"disease_priors_used":true,"disease_priors_version":"v1.0_bootstrap","priors_refresh_date":"2025-12-31","platinum_proxy_used":false,"confidence_version":"v1.0","estimates":{"tmb":{"value":5.2,"source":"disease_prior"},"msi_status":{"value":null,"source":"unknown"},"hrd_score":{"value":42,"source":"disease_prior"}}},"confidence_cap":0.4,"recommendations":["Level 0 analysis: Based on disease priors only. Tumor NGS recommended for refined analysis.","MSI status unknown. MSI testing (IHC/PCR or NGS) recommended for immunotherapy eligibility."]}
